Skip to main content
Premium Trial:

Request an Annual Quote

Modular Genetics Closes First Round of $5.5M Series B Financing

NEW YORK, June 30 (GenomeWeb News) - Modular Genetics has closed the first round of a $5.5 million Series B financing, the Woburn, Mass.-based company said today.


According to an official statement, Modular Genetics will use the cash to enhance its automated gene engineering system, expand its sales force, and accelerate specific product development programs.


Molecular Genetics' core technology, CombiGenix, is used for automated assembly and modification of cloned genes, and is the basis of three of the company's gene engineering platforms: GeneDirect, a 96-sample platform for site-directed mutagenesis; GeneBuild, for codon optimization and assembly of custom genes; and GeneFix, for repairing mutations or removing introns from cloned genes.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.